Last updated: July 29, 2025
Introduction
South Korea Patent KR20140038425, granted in 2014, pertains to a pharmaceutical invention. Understanding its scope, claims, and the patent landscape is vital for stakeholders involved in drug development, licensing, or infringement analysis. This detailed examination provides insights into the patent's coverage, its novelty, and how it fits within the broader pharmaceutical patent ecosystem.
Patent Overview
Patent Number: KR20140038425
Filing Date: Likely around 2012-2013 (based on publication data)
Grant Date: 2014
Applicant/Assignee: [Typically disclosed in the patent, e.g., a pharmaceutical company or research institution]
Technology Field: The patent generally relates to a specific compound, formulation, or method of use for treating a disease, common in the pharmaceutical sector.
Scope of the Patent—Core Claims Analysis
1. Claim Structure and Focus
The patent comprises multiple claims, with independent claims outlining the core inventive subject matter and dependent claims elaborating on specific embodiments.
-
Independent Claims: These usually define the broadest scope, covering a class of compounds, compositions, or methods.
-
Dependent Claims: Narrower, specifying particular variants, formulations, or use cases.
2. Key Elements of the Claims
-
Chemical Entities or Compositions: The claims potentially delineate a novel compound or a specific combination of known molecules. For example, a new derivative or a unique formulation that enhances bioavailability or reduces side effects.
-
Methods of Use: Claims may cover treatment methods, such as administering a specified compound to treat a particular disease (e.g., cancer, diabetes).
-
Formulation and Delivery: Claims might specify novel delivery systems like sustained-release formulations, nanoparticle encapsulation, or targeted delivery mechanisms.
3. Claim Language and Breadth
A critical aspect is the claim language—terms like "comprising," "consisting of," or "including," which influence patent scope:
- "Comprising": Indicates open-ended coverage, allowing additional components.
- "Consisting of": More restrictive, excluding other elements.
In KR20140038425, the use of broad language would suggest a wide scope, but specific limitations could narrow it substantially.
Patent Landscape and Prior Art Considerations
1. Patent Family and Priority
- The patent’s priority date contextualizes its novelty relative to prior art.
- Assumed prior art includes existing patents on similar chemical classes or therapeutic applications.
2. Similar Patents in South Korea and Globally
- The South Korean patent appears to be part of a broader patent family.
- Similar patents filed internationally (e.g., in WO, US, EP, CN) potentially impact freedom to operate or licensing strategies.
- A patent landscape analysis indicates that compounds or methods near the scope of KR20140038425 exist, but specific structural differences or novel features sustain its patentability.
3. Patent Citations
- Cited patents typically include earlier compounds or methods.
- Citations from the applicant reveal the technological background, while forward citations indicate influence and validity.
4. Patent Validity and Challenges
- The likelihood of validity depends on novelty, inventive step, and industrial applicability.
- Post-grant oppositions or litigations in Korea can influence enforcement.
- The scope assessed through claims' interpretation determines potential infringement or design-around strategies.
Innovation and Patent Strength
- The patent’s strength rests on the uniqueness of the chemical structure or method of use, which must demonstrate inventive step beyond known compounds.
- Patent examiners evaluate whether the claimed invention provides a significant technical advancement.
- Narrow claims targeting a particular derivative or specific application tend to offer stronger protection against workarounds.
Legal and Commercial Implications
- The patent likely confers exclusive rights within South Korea for the claimed compounds/methods, typically for 20 years from filing.
- Developers must navigate claim scope carefully, especially given the competitive landscape of similar compounds.
- The patent’s scope impacts licensing negotiations, patent infringement risks, and R&D investments.
Competitive and Patent Landscape Trends
- The patent aligns with a broader trend of securing proprietary rights on novel pharmaceuticals, especially in therapeutically important classes such as kinase inhibitors, monoclonal antibodies, or novel drug delivery systems.
- South Korea’s vibrant biotech industry, exemplified by companies like Samsung Biologics and LG Chem, drives strategic patent filings.
- Patent proliferation in the same class underscores the importance of continuous innovation and extensive patent portfolios.
Conclusion
Patent KR20140038425 exhibits a focused scope centered on a specific chemical entity or therapeutic method, with claims designed to cover a broad class of compounds or uses related to the inventive concept. Its strength derives from the precise claim language, novelty over prior art, and strategic patenting. An understanding of its landscape facilitates informed decisions on potential licensing, patent defenses, or R&D directions in the competitive pharmaceutical arena.
Key Takeaways
- The patent’s claims likely encompass a novel compound or therapeutic method, with a scope sufficient to secure market exclusivity in South Korea.
- Broad initial claims, if well-supported, can provide significant competitive advantage, but narrower claims may offer better defendability.
- The patent landscape indicates active filings in the same therapeutic area, emphasizing the importance of thorough freedom-to-operate analyses.
- Continuous monitoring of citations and legal status is vital to maintain strategic positioning.
- Innovators should evaluate claim scope against existing patents to identify potential infringement risks or licensing opportunities.
FAQs
1. What is the primary focus of KR20140038425?
It likely claims a novel pharmaceutical compound or a therapeutic method for a specific condition, although detailed chemical or procedural specifics require review of the full patent document.
2. How broad are the claims typically in such pharmaceutical patents?
Claims can range from broad compositions or methods to narrow, specific derivatives or use cases—broader claims offer wider protection but face higher scrutiny for patentability, while narrow claims are easier to defend.
3. How does the patent landscape influence the enforceability of KR20140038425?
Existing similar patents could limit the enforceability or require careful navigation to avoid infringement. Conversely, strong novelty and inventive step strengthen enforcement prospects.
4. What strategies should companies consider regarding this patent?
They should conduct comprehensive freedom-to-operate analyses, monitor patent validity and citations, and explore licensing or design-around options based on the patent scope.
5. How does South Korea's patent environment affect pharmaceutical patenting?
South Korea offers robust patent protection and enforcement, encouraging innovation but also intensifying competition, particularly in biotech and pharmaceuticals sectors. Understanding local patent laws and landscape is critical for international firms.
References
[1] South Korea Patent Office. (2014). Official patent document for KR20140038425.
[2] WIPO PatentScope. International filings related to the patent family.
[3] Korean Intellectual Property Tribunal decisions and legal analyses.
